Digital Health APAC

APAC AI in Pathology Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

APAC AI in Pathology Market Industry Trends and Forecast to 2034: Segmented by (Application, Component, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

APAC · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $47.8 Mn Placeholder estimate
Estimate 2025 $61.6 Mn 18.8% of the global market
Projected 2034 $605.6 Mn 882.4% Adds $543.9 Mn over 9 forecast years
CAGR 2025–2034 28.9% Faster than 89% of 100 Digital Health markets here
Key players 6 +1
  • APAC is 18.81% of the global market.
  • Among regions, the largest is North America at $138.2 Mn.
  • Fastest growing: Africa at 29.5% a year.
  • APAC ranks 2nd of 6 by size among regions.

Market size projection

APAC

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$543.9 Mn total, 2026–2034

Year-by-year market size, 2024–2034
AI in Pathology Market market size by year, APAC
YearMarket sizeChange that yearSince 2025
2024 (estimate) $47.8 Mn — —
2025 (base) $61.6 Mn +$13.8 Mn —
2026 (forecast) $79.5 Mn +$17.8 Mn +28.9%
2027 (forecast) $102.4 Mn +$23.0 Mn +66.2%
2028 (forecast) $132.0 Mn +$29.6 Mn +114.2%
2029 (forecast) $170.2 Mn +$38.2 Mn +176.1%
2030 (forecast) $219.4 Mn +$49.2 Mn +255.8%
2031 (forecast) $282.7 Mn +$63.4 Mn +358.7%
2032 (forecast) $364.5 Mn +$81.7 Mn +491.2%
2033 (forecast) $469.8 Mn +$105.3 Mn +662.1%
2034 (forecast) $605.6 Mn +$135.8 Mn +882.4%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

APAC AI in Pathology Market Analysis at a glance
Market size, 2025$61.6 Mn placeholder estimate
Forecast, 2034$605.6 Mn placeholder estimate
Growth (CAGR), 2025–203428.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsApplication, component and end user (see all)
Key playersPaige, PathAI, Ibex Medical Analytics, Philips Healthcare, Roche and 1 more (see all)
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The APAC AI in Pathology Market Analysis Executive Summary

AI in pathology analyses digital images of tissue slides to help pathologists find cancer and other diseases faster and more consistently.

Key segments of the AI in Pathology market include application (Cancer Detection, Grading and Biomarker Scoring) and component (Software and Services).

Bar chart: Asia Pacific AI in Pathology market size, 2024–2034, placeholder estimates. $47.8 Mn in 2024, $61.6 Mn in 2025 and $605.6 Mn in 2034, 28.9% CAGR.
Asia Pacific AI in Pathology market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

APAC AI in Pathology Market Dynamics

Market Growth Drivers

Advances in machine learning and large language models, more digital health data, clinician shortages and pressure to cut costs are driving the AI in Pathology market. Health systems are moving from pilots to wider use.

Opportunity

Generative AI, automation of paperwork and AI tools approved as medical devices give the AI in Pathology market strong growth, including in emerging health systems.

Market Restraints

Concerns about accuracy, bias, privacy and liability, along with unclear regulation and the cost of fitting AI into clinical workflows, hold back the AI in Pathology market.

Competitive Landscape for AI in Pathology Market in APAC

The AI in Pathology market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for AI in Pathology Market in APAC

AI in Pathology in APAC: rules and payment

In some of the countries we cover here, rules for health software come from TGA (Australia)⁠[1], NMPA (China)⁠[2] and PMDA (Japan)⁠[3]. How care is paid for in some of these countries: Medicare and the PBS (Australia)⁠[4], basic medical insurance (China)⁠[5], the Hospital Authority (Hong Kong)⁠[6], Ayushman Bharat PM-JAY (India)⁠[7], public health insurance (Japan)⁠[8], subsidised public care (Malaysia)⁠[9], Pharmac (New Zealand)⁠[10], PhilHealth (Philippines)⁠[11], MediShield Life (Singapore)⁠[12] and the Universal Coverage Scheme (Thailand)⁠[13].

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] National Medical Products Administration. Checked 14 Nov 2026.

[3] Pharmaceuticals and Medical Devices Agency. Checked 14 Nov 2026.

[4] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

[5] National Healthcare Security Administration. Checked 14 Nov 2026.

[6] Hospital Authority. Checked 14 Nov 2026.

[7] National Health Authority (PM-JAY). Checked 14 Nov 2026.

[8] Ministry of Health, Labour and Welfare. Checked 14 Nov 2026.

[9] Ministry of Health Malaysia. Checked 14 Nov 2026.

[10] Pharmac. Checked 14 Nov 2026.

[11] PhilHealth. Checked 14 Nov 2026.

[12] CPF Board, MediShield Life. Checked 14 Nov 2026.

[13] National Health Security Office. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the AI in Pathology market. Government digital health programs in APAC are speeding up adoption.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in AI in Pathology right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

AI in Pathology in context

Free data on this topic

Quick answers

Frequently asked questions

How big is the AI in Pathology market in Asia Pacific?
Placeholder estimate: about $61.6 Mn in 2025, rising to about $605.6 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the AI in Pathology market in Asia Pacific growing?
Placeholder estimate: about 28.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the AI in Pathology market report cover?
The report splits the market by application (Cancer Detection, Grading, Biomarker Scoring, Workflow Triage), component (Software, Services) and end user (Healthcare Providers, Patients, Payers, Pharmaceutical Companies).
Who are the key players in the AI in Pathology market?
Key players include Paige, PathAI, Ibex Medical Analytics, Philips Healthcare, Roche and Proscia.
What is driving the AI in Pathology market?
Advances in machine learning and large language models, more digital health data, clinician shortages and pressure to cut costs are driving the AI in Pathology market. Health systems are moving from pilots to wider use.
How much research is published on AI in Pathology?
PubMed lists 55 papers on AI in Pathology added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Back to Catalogue

Related Digital Health reports in APAC

See all

Related on artificial intelligence and diagnostics and lab testing

See the topic